Parallax Volatility Advisers, L.P. Clearside Biomedical, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$6.03 - $11.24 $61,861 - $115,311	-10,259 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$8.91 - $14.54 $4,455 - $7,270	-500 Reduced 4.65%	10,259 $110,000
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $42,616 - $109,256	7,651 Added 246.17%	10,759 $115,000
Q4 2017 Feb 14, 2018	BUY	$5.78 - $9.12 $17,964 - $28,344	3,108	3,108 $22,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $59.6M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.